Article Versions Notes

Salmen T, Rizvi AA, Rizzo M, Pietrosel V-A, Bica I-C, Diaconu CT, Potcovaru CG, Salmen B-M, Coman OA, Bobircă A, et al. Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study. Biomedicines. 2023; 11(9):2455. https://doi.org/10.3390/biomedicines11092455

Salmen, Teodor, Ali Abbas Rizvi, Manfredi Rizzo, Valeria-Anca Pietrosel, Ioana-Cristina Bica, Cosmina Theodora Diaconu, Claudia Gabriela Potcovaru, Bianca-Margareta Salmen, Oana Andreia Coman, Anca Bobircă, and et al. 2023. "Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study" Biomedicines 11, no. 9: 2455. https://doi.org/10.3390/biomedicines11092455

Salmen, T., Rizvi, A. A., Rizzo, M., Pietrosel, V.-A., Bica, I.-C., Diaconu, C. T., Potcovaru, C. G., Salmen, B.-M., Coman, O. A., Bobircă, A., Stoica, R.-A., & Pantea Stoian, A. (2023). Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study. Biomedicines, 11(9), 2455. https://doi.org/10.3390/biomedicines11092455